37^th Experts Meet On Cancer Research & Therapy

About the Conference

Call for Abstracts

The 37th Experts Meet on Cancer Research & Therapy invites researchers, oncologists, clinicians, healthcare professionals, academicians, and students to submit abstracts for consideration for oral and poster presentations.

We welcome original research, clinical studies, review-based scientific contributions, case studies, and innovative findings related to cancer research, oncology, and therapeutic development.

Registration

Registration is open to interested researchers, oncologists, clinicians, academicians, healthcare professionals, pharmaceutical and biotechnology representatives, and students seeking to participate in this international scientific meeting.

Attendees can take part in scientific sessions, explore emerging developments in oncology, exchange research insights, and build connections with professionals from diverse scientific and clinical backgrounds.

Secure your participation and join us for two days of scientific exchange and collaboration.

Please visit the official conference website for registration categories, fees, deadlines, and participation details. Early registration is encouraged, subject to the published registration schedule.

Sessions and Tracks

Cancer Research and Molecular Oncology

This track explores the molecular and cellular mechanisms responsible for cancer development, progression, and treatment response. Topics include oncogenes, tumor suppressor genes, cellular signaling pathways, mutations, and molecular interactions involved in tumor formation. Researchers are encouraged to share discoveries that improve understanding of cancer biology and identify potential therapeutic targets.

Cancer Biology, Genetics and Epigenetics

This session focuses on the genetic and epigenetic changes that contribute to cancer initiation and progression. Topics include inherited cancer susceptibility, somatic mutations, gene expression, DNA methylation, histone modifications, and epigenetic regulation. The track highlights how genetic and epigenetic research can support cancer risk assessment, diagnosis, prognosis, and therapeutic development.

Cancer Immunotherapy and Immuno-Oncology

This track examines how the immune system can be stimulated or modified to recognize and eliminate cancer cells. Topics include immune checkpoint inhibitors, CAR-T cell therapy, monoclonal antibodies, cancer vaccines, immune cell engineering, and tumor immune evasion. Contributions addressing treatment resistance, immunotherapy combinations, and biomarkers of therapeutic response are welcome.

Precision Medicine and Personalized Cancer Treatment

This session highlights individualized cancer treatment based on a patient's tumor characteristics, molecular profile, genetic alterations, and relevant clinical factors. Topics include genomic profiling, biomarker-guided treatment selection, targeted therapies, pharmacogenomics, and personalized treatment planning. The track also explores challenges in implementing precision oncology in clinical practice.

Chemotherapy, Radiotherapy and Targeted Therapy

This track focuses on established and emerging therapeutic approaches for managing different types of cancer. Topics include conventional and combination chemotherapy, advanced radiation techniques, molecularly targeted drugs, treatment optimization, and strategies for reducing adverse effects. Researchers may present findings on treatment effectiveness, resistance mechanisms, and innovative therapeutic combinations.

Clinical Oncology and Translational Cancer Research

This session connects laboratory-based discoveries with clinical applications to improve cancer diagnosis and treatment. Topics include clinical oncology research, patient outcomes, translational studies, multidisciplinary treatment approaches, and the development of new therapeutic strategies. The track encourages collaboration between laboratory scientists, clinicians, and healthcare professionals to advance evidence-based cancer care.

Cancer Prevention, Screening and Early Detection

This track explores strategies for reducing cancer risk and identifying malignancies at earlier stages. Topics include population-based screening, risk assessment, preventive interventions, early diagnostic technologies, hereditary cancer screening, and public health initiatives. Contributions may examine approaches to improving screening participation, early diagnosis, and access to preventive services.

Cancer Biomarkers and Molecular Diagnostics

This session focuses on identifying biological indicators that support cancer detection, diagnosis, prognosis, and treatment monitoring. Topics include molecular biomarkers, genomic and proteomic profiling, circulating tumor DNA, liquid biopsy, companion diagnostics, and predictive markers of treatment response. The track highlights developments that may support more accurate and timely clinical decision-making.

Cancer Stem Cells and Tumor Microenvironment

This track examines the role of cancer stem cells and the surrounding tumor microenvironment in cancer progression, metastasis, and therapeutic resistance. Topics include tumor–immune interactions, stromal cells, extracellular matrix, cellular signaling, tumor heterogeneity, and mechanisms of tumor recurrence. Research exploring new strategies to target cancer stem cells and modify the tumor microenvironment is encouraged.

Metastasis, Tumor Progression and Angiogenesis

This session addresses the biological processes that enable cancer cells to invade surrounding tissues and spread to distant organs. Topics include epithelial–mesenchymal transition, tumor invasion, angiogenesis, circulating tumor cells, metastatic colonization, and organ-specific metastasis. The track also explores molecular mechanisms and potential therapeutic strategies for limiting cancer progression and metastatic disease.

Novel Anticancer Drugs and Drug Discovery

This track highlights advances in identifying, developing, and evaluating new anticancer agents. Topics include small-molecule inhibitors, biologics, antibody–drug conjugates, drug repurposing, computational drug discovery, preclinical testing, and therapeutic development. Researchers may share findings on drug design, pharmacological evaluation, safety assessment, and strategies to overcome treatment resistance.

Nanotechnology and Drug Delivery in Cancer Therapy

This session explores the application of nanotechnology to improve the delivery and performance of cancer treatments. Topics include nanoparticles, liposomes, polymeric drug carriers, targeted drug delivery, nanomedicine, controlled-release systems, and theranostic platforms. The track examines research aimed at enhancing therapeutic delivery, improving drug distribution, and reducing unintended effects on healthy tissues.

Artificial Intelligence and Emerging Technologies in Oncology

This track examines how artificial intelligence, machine learning, and digital technologies are being applied to cancer research and clinical care. Topics include AI-assisted medical imaging, digital pathology, computational oncology, predictive modeling, clinical decision-support tools, and data-driven treatment planning. Discussions may also address data quality, algorithm validation, patient privacy, and responsible implementation of emerging technologies.

Hematologic Malignancies and Blood Cancer Research

This session focuses on cancers affecting blood, bone marrow, and the lymphatic system. Topics include leukemia, lymphoma, multiple myeloma, molecular classification, hematologic diagnostics, targeted treatments, and cellular therapies. The track welcomes research on disease mechanisms, treatment response, minimal residual disease, and emerging approaches to managing hematologic malignancies.

Pediatric Oncology and Childhood Cancer Research

This track addresses the scientific and clinical challenges associated with cancers affecting infants, children, and adolescents. Topics include childhood leukemia, pediatric brain tumors, neuroblastoma, sarcomas, genetic predisposition, treatment development, and survivorship. Research may focus on age-appropriate therapies, reducing long-term treatment effects, and improving supportive care for young patients and their families.

Surgical Oncology and Multidisciplinary Cancer Care

This session explores advances in surgical approaches to cancer diagnosis and treatment, alongside coordinated care involving multiple medical specialties. Topics include tumor resection, minimally invasive and robotic surgery, surgical planning, perioperative management, and integration with systemic therapy and radiotherapy. The track emphasizes treatment coordination, clinical outcomes, recovery, and patient-centered decision-making.

Cancer Epidemiology and Public Health

This track investigates cancer incidence, prevalence, mortality, risk factors, and population-level patterns of disease. Topics include environmental and occupational exposures, lifestyle factors, infectious causes of cancer, cancer registries, health disparities, and prevention policies. Contributions may explore public health interventions and strategies to improve equitable access to screening, diagnosis, and treatment.

Clinical Trials and Innovative Therapeutic Approaches

This session focuses on the design, implementation, and evaluation of clinical trials investigating new cancer treatments and diagnostic approaches. Topics include early- and late-phase trials, combination therapies, targeted treatment studies, immunotherapy trials, trial methodology, patient recruitment, and clinical outcome assessment. The track also welcomes research on trial ethics, patient safety, and translating promising findings into clinical practice.

Palliative Care, Cancer Survivorship and Quality of Life

This track highlights comprehensive care for individuals living with cancer throughout treatment, recovery, and survivorship. Topics include symptom management, pain control, psychosocial support, rehabilitation, nutritional care, palliative oncology, and long-term treatment effects. The session emphasizes patient-centered approaches to maintaining quality of life and addressing the physical, emotional, and social needs of patients and their families.

Emerging Trends and Future Perspectives in Cancer Research

This session provides a platform for discussing innovative concepts and emerging directions in cancer science and therapy. Topics may include gene and cell-based therapies, RNA therapeutics, cancer vaccines, organoid models, multi-omics, microbiome research, advanced imaging, and novel treatment combinations. The track encourages interdisciplinary perspectives on scientific challenges, research opportunities, and future developments in oncology.